PRESS DIGEST- British Business - April 25
April 25 The following are the top stories on the business pages of British newspapers. Reuters has not verified these stories and does not vouch for their accuracy.
Jan 11 Mylan NV
* U.S. FDA accepts biologics license application (BLA) for Mylan and Biocon's proposed biosimilar trastuzumab
* Mylan NV- anticipated FDA goal date set under Biosimilar User Fee Act (BSUFA) is Sept. 3, 2017
* Mylan nv - Mylan and Biocon's proposed biosimilar trastuzumab is also under review by European Medicines Agency (EMA) Source text for Eikon: Further company coverage:
SANTIAGO, April 24 A strong earthquake of magnitude 6.9 struck off the west coast of Chile on Monday, rocking the capital Santiago and briefly causing alarm along the Pacific Coast but sparing the quake-prone nation of any serious damage.